Challenges facing new biobanks, strategies for cost recovery and sustainability

March 23, 2012 - PRLog -- Access to samples is paramount to scientific research. Biological samples such as DNA, RNA, proteins, cells and tissues are collected from donors, processed and stored centrally for later use in experiments conducted by academia and industry alike. This has given rise to the concept of Biobanking. In 2009 the market for biobanking products and services was estimated to be worth $8B and is expected to reach $45B by 2025. UK and European biobanks are enjoying rapid growth and there is now greater impetus being put on data sharing, interoperability and harmonisation of biobanks worldwide.

SMi’s 2nd annual Biobanking event will reflect the significant change driving current development in bio sample management. With great impetus being put on data sharing, interoperability and harmonisation of biobanks, it will explain how single centre research facilities are evolving into research infrastructures. There will also be efforts to associate value to existing biological resources and coverage of important issues experienced by those who donate, manage and expend biobank samples.

Why attend this event?

•   Explore challenges facing new biobanks, strategies for cost recovery and sustainability
•   Discover sample requirements of researchers in drug discovery
•   Communicate with solution providers who provide technological innovations for managing biobanks
•   Examine quality control and quality assurance practices
•   Determine how to improve your infrastructure and better network with the biobanking community
•   Discuss obstacles to people donating tissue for biomedical research

For more information visit http://www.smi-online.co.uk/bio-banking-event28.asp
Alternatively contact Fateja Begum on tel: +44 (0) 20 7827 6184 or Email: fbegum@smi-online.co.uk